| Literature DB >> 34764893 |
Yongtao Xie1,2, Xuping Gao3, Yiling Song1, Xiaotong Zhu1, Mengge Chen1, Li Yang3, Yuanchun Ren1.
Abstract
Objective: To assess the effectiveness of physical activity (PA) intervention on attention-deficit/hyperactivity disorder (ADHD)-related symptoms. Method: Studies that investigated PA intervention for ADHD-related symptoms were identified through searching PubMed, Web of Science, Cochrane Library, and Embase databases from inception through June 2021. Standardized mean difference (SMD) with 95% confidence interval (CI) was used to assess the effectiveness of PA intervention on improving ADHD-related symptoms. The meta-analyses were conducted using fixed-effect or random-effect models according to the heterogeneity of the studies.Entities:
Keywords: attention-deficit/hyperactivity disorder; effectiveness; intervention; motor skill; physical activity
Year: 2021 PMID: 34764893 PMCID: PMC8575983 DOI: 10.3389/fpsyt.2021.706625
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Figure 1PRISMA flowchart.
Summary of design and participant characteristics of studies included in meta-analyses.
|
|
|
|
|
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| ||||||||
| Jensen et al. (2004, Australia) ( | Non-RCT | DSM-IV | NR | 11/8 | 0 | 8–13 | NR | NR | NR | NR | Closed | √ | √ | √ | √ |
| Verret et al. (2012, Canada) ( | Non-RCT | DSM-IV | NR | 9/9 | 10 | 7–12 | Moderate-to-vigorous | 45 | 3 | 10 | Open | √ | – | √ | √ |
| So et al. (2017, Korea) ( | Non-RCT | Clinician | NR | 10 | NR | 10–12 | NR | 30 | 2 | 4 | Open | √ | – | √ | – |
| Kallweit et al. (2019, Germany) ( | Non-RCT | DSM-IV | NR | 36 | 44 | 22–41 | Moderate-to-vigorous | 10 | NR | NR | Closed | √ | √ | – | — |
| Converse et al. (2020, America) ( | Non-RCT | Clinician | NR | 9/4 | 67 | 18–23 | NR | 60 | 2 | 7 | Closed | √ | √ | – | — |
| Kang et al. (2011, Republic of Korea) ( | RCT | Clinician | Yes | 15/13 | NR | 7–9 | Moderate | 90 | 2 | 6 | Closed | √ | √ | – | — |
| Hoza et al. (2015, America) ( | RCT | DISC-IV | No | 49/45 | 47 | 4–8 | Moderate-to-vigorous | 31 | 5 | 12 | Open | √ | √ | √ | √ |
| Zhang et al. (2015, China) ( | RCT | Clinician | NR | 15/15 | 50 | 6–12 | Moderate | 30 | 3 | 10 | Open | – | – | √ | — |
| Pan et al. (2016, China) ( | RCT | DSM-IV | NR | 16/16 | 0 | 6–12 | Moderate | 70 | 2 | 12 | Open | √ | – | √ | √ |
| Bustamante et al. (2016, America) ( | RCT | DISC-IV | NR | 19/16 | 31 | 6–12 | Moderate-to-vigorous | 105 | 5 | 10 | Open | √ | √ | – | √ |
| García-Gómez et al. (2016, Spain) ( | RCT | Clinician | NR | 9/5 | 14 | 7–14 | NR | 45 | 2 | 12 | Open | √ | √ | √ | √ |
| Geladé et al. (2017, Netherlands) ( | RCT | DSM-IVTR | No | 31 | 32 | 7–13 | Moderate-to-vigorous | 20 | 3 | 10 | NR | √ | √ | – | – |
| Oh et al. (2018, Korea) ( | RCT | DSM-IVTR | No | 17 | 12 | 6–12 | NR | 60 | 2 | 12 | Open | √ | √ | √ | √ |
| Silva et al. (2019, Brasilia) ( | RCT | DSM-IV | NR | 10/10 | 30 | 11–14 | Moderate | 45 | 2 | 8 | Closed | – | – | √ | – |
| Hernandez-Reif et al. (2000, America) ( | Self-control | Clinician | NR | 13 | 15 | 13–16 | NR | NR | 2 | NR | Closed | – | √ | √ | √ |
| Lufi (2011, Israel) ( | Self-control | DSM-IVTR | No | 15 | 0 | 8–13 | NR | 90 | 1 | 20 | Open | √ | – | √ | √ |
| Smith et al. (2013, America) ( | Self-control | DSM-IV | No | 14 | 12 | 5–8 | Moderate-to-vigorous | 26 | 5 | 8 | Open | – | √ | – | √ |
| Cuypers et al. (2011, Norway) ( | Self-control | Clinician | Yes | 5 | 0 | 10–11 | NR | 60 | 2 | 24 | Open | – | – | √ | √ |
| Fritz et al. (2015, America) ( | Self-control | ASRS V1.1 | No | 32 | 0 | 18–34 | Moderate | 20 | NR | NR | Closed | – | – | √ | – |
| Jang et al. (2015, Republic of Korea) ( | Self-control | DSM-IVTR | No | 20 | 5 | 6–13 | NR | 30–60 | 2 | 12 | Open | √ | √ | – | – |
| Schoenfelder et al. (2017, America) ( | Self-control | Clinician | NR | 11 | 54 | 14–18 | NR | NR | NR | NR | Closed | √ | √ | √ | – |
| Shema-Shiratzky et al. (2019, Israel) ( | Self-control | DSM-5 | No | 14 | 21 | 8–11 | NR | 90–180 | 3 | 6 | Open | √ | √ | √ | √ |
| Siu et al. (2020, China) ( | Self-control | Clinician | NR | 14 | 29 | 7–9 | Moderate-to-vigorous | 90 | 1 | 6 | Open | √ | √ | – | – |
The sample size of each study, the number before slash indicated the intervention group size, and the number after the slash indicated the control group size.
NR, not report; RCT, randomized control trial.
Figure 2Forest plots for physical activity intervention on ADHD symptoms in before–after studies. (A) Attention problems; (B) hyperactive/impulsive problems; (C) emotional problems; (D) behavioral problems. CI, confidence interval; SMD, standardized mean difference.
Figure 3Forest plots for physical activity intervention on ADHD symptoms in two-group control studies. (A) Attention problems; (B) hyperactive/impulsive problems; (C) emotional problems; (D) behavioral problems. CI, confidence interval; SMD, standardized mean difference.
Pooled effect size for physical activity intervention on attention problems.
|
|
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||
|
| 16 | 0.604 | 0.374, 0.834 | <0.001 | 51.1% | 0.010 | 8 | 0.715 | 0.105, 1.325 | 0.022 | 84.0% | <0.001 | |
|
| |||||||||||||
| Yes | 14 | 0.603 | 0.320, 0.885 | <0.001 | 56.1% | 0.005 | 6 | 1.056 | 0.140, 1.972 | 0.024 | 84.8% | <0.001 | |
| No | 2 | 0.635 | 0.371, 0.899 | <0.001 | 0.0% | 0.560 | 2 | 0.059 | −0.204, 0.323 | 0.659 | 0.0% | 0.851 | |
|
| |||||||||||||
| Children | 14 | 0.678 | 0.431, 0.926 | <0.001 | 50.8% | 0.015 | 7 | 0.776 | 0.101, 1.451 | 0.024 | 86.3% | <0.001 | |
| Adults | 2 | 0.135 | −0.278, 0.549 | 0.522 | 0.0% | 0.881 | 1 | 0.327 | −0.714, 1.368 | 0.538 | – | – | |
|
| |||||||||||||
| Closed | 5 | 0.687 | −0.020, 1.395 | 0.057 | 77.0% | 0.002 | 3 | 0.909 | −0.540, 2.359 | 0.219 | 87.6% | <0.001 | |
| Open | 10 | 0.671 | 0.487, 0.855 | <0.001 | 0.0% | 0.641 | 5 | 0.604 | −0.127, 1.336 | 0.105 | 84.3% | <0.001 | |
|
| |||||||||||||
| Moderate | 2 | 1.426 | 0.163, 2.689 | 0.027 | 83.0% | 0.015 | 2 | 1.550 | −0.066, 3.166 | 0.060 | 88.1% | 0.004 | |
| Moderate-to-vigorous | 5 | 0.419 | 0.175, 0.663 | 0.001 | 33.6% | 0.197 | 3 | 0.951 | −0.328, 2.230 | 0.145 | 90.0% | <0.001 | |
|
| |||||||||||||
| <3 times per week | 9 | 0.787 | 0.392, 1.182 | <0.001 | 53.8% | 0.027 | 4 | 0.838 | −0.133, 1.808 | 0.091 | 79.5% | 0.002 | |
| ≥3 times per week | 4 | 0.488 | 0.215, 0.760 | <0.001 | 33.6% | 0.210 | 3 | 0.951 | −0.328, 2.230 | 0.145 | 90.0% | <0.001 | |
|
| |||||||||||||
| Yes | 1 | 1.512 | 0.694, 2.330 | 0.000 | – | – | – | – | – | – | – | – | – |
| No | 6 | 0.993 | 0.349, 1.636 | 0.002 | 83.8% | 0.000 | – | – | – | – | – | – | – |
95% CI, 95% confidence interval; SMD, standardized mean difference.
Pooled effect size for physical activity intervention on hyperactive/impulsive problems.
|
|
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
| ||||
|
| 15 | 0.676 | 0.401, 0.950 | <0.001 | 66.3% | <0.001 | 6 | 0.031 | −0.192, 0.254 | 0.787 | 37.6% | 0.155 | |
|
| |||||||||||||
| Yes | 13 | 0.650 | 0.322, 0.978 | <0.001 | 68.2% | <0.001 | 4 | 0.350 | −0.068, 0.768 | 0.101 | 37.8% | 0.185 | |
| No | 2 | 0.828 | 0.251, 1.405 | 0.005 | 59.2% | 0.117 | 2 | −0.096 | −0.360, 0.168 | 0.475 | 0.0% | 0.791 | |
|
| |||||||||||||
| Children | 13 | 0.770 | 0.478, 1.062 | <0.001 | 65.3% | 0.001 | 5 | 0.041 | −0.188, 0.269 | 0.727 | 49.1% | 0.097 | |
| Adults | 2 | 0.049 | −0.364, 0.463 | 0.815 | 0.0% | 0.921 | 1 | −0.172 | −1.207, 0.863 | 0.745 | – | – | |
|
| |||||||||||||
| Closed | 6 | 0.624 | 0.106, 1.143 | 0.018 | 71.2% | 0.004 | 3 | 0.455 | 0.002, 0.907 | 0.049 | 41.1% | 0.183 | |
| Open | 8 | 0.818 | 0.466, 1.170 | <0.001 | 55.6% | 0.027 | 3 | −0.105 | −0.362, 0.151 | 0.420 | 0.0% | 0.924 | |
|
| |||||||||||||
| Moderate | 1 | 1.512 | 0.694, 2.330 | <0.001 | – | – | 1 | 1.004 | 0.213, 1.796 | 0.013 | - | - | |
| Moderate-to-vigorous | 6 | 0.434 | 0.123, 0.744 | 0.006 | 58.3% | 0.035 | 2 | −0.096 | −0.360, 0.168 | 0.475 | 0.0% | 0.791 | |
|
| |||||||||||||
| <3 times per week | 7 | 0.918 | 0.356, 1.480 | 0.001 | 69.9% | 0.003 | 3 | 0.254 | −0.613, 1.122 | 0.565 | 58.5% | 0.090 | |
| ≥3 times per week | 5 | 0.617 | 0.283, 0.951 | <0.001 | 54.1% | 0.069 | 2 | −0.096 | −0.360, 0.168 | 0.475 | 0.0% | 0.791 | |
|
| |||||||||||||
| Yes | 1 | 2.129 | 1.222, 3.037 | 0.000 | – | – | – | – | – | – | – | – | – |
| No | 5 | 0.837 | 0.339, 1.335 | 0.001 | 71.0% | 0.008 | – | – | – | – | – | – | – |
95% CI, 95% confidence interval; SMD, standardized mean difference.